iiinova — where your digital self keeps evolving

Reposted by EANO

European Organisation for Research and Treatment of Cancer @eortc.org · 28/09/2026

From ROAM/EORTC 1308 to VIGOR and new glioma research, EORTC abstracts contributed important evidence presented at #EANO2026. 🔗 Read more: www.eortc.org/blog/2026/09/28/eortc… EANO #EORTCbrain

011

EANO @eanoassociation.bsky.social · 28/09/2026

Presented at this year’s #EANO2026 Congress in Rome and simultaneously published in The Lancet. Thank you to @thelancet.com for the excellent collaboration!

010

Reposted by EANO

Raffaella De Pietro @rdepietro.bsky.social · 27/09/2026

Interesting data from #STERIMGLI at #EANO2026 on #re-irradiation + #durvalumab for recurrent glioblastoma: ➡️ HF-SRT 24 Gy/3 fx ➡️ Primary OS endpoint not met in ITT population (16.1 vs 13.3 months) ➡️ QoL and cognition maintained ➡️ Exploratory analyses suggest a stronger OS in WHO 2021 glioblastoma

031

Reposted by EANO

Raffaella De Pietro @rdepietro.bsky.social · 27/09/2026

Now at #EANO2026 on #radiotherapy in glioblastoma 🧠: ➡️ #FET-PET-informed target volumes were larger than MRI-only volumes ➡️ MRI-based plans showed lower coverage 📄Take-home: MRI-only planning may under-cover disease, but whether this translates into better tumour control still needs to be shown

042

EANO @eanoassociation.bsky.social · 27/09/2026

📢 Just presented at #EANO2026 – and now published in Neuro-Oncology! The study “Impact of [18F]FET-PET on MRI-Based Radiotherapy Target Volumes in Newly Diagnosed Glioblastoma: Results from the FET-PET in Glioblastoma (FIG) Study TROG 18.06”, presented by Eng-Siew Koh: doi.org/10.1093/neuo...

011

EANO @eanoassociation.bsky.social · 27/09/2026

The final day of the #EANO2026 scientific programme is underway in Rome! There is still plenty of science, clinical research and exchange ahead as we come together for another day across the #NeuroOncology community. www.eano.eu/eano2026/pro... #btsm #BrainTumor #EANO

110

Reposted by EANO

Raffaella De Pietro @rdepietro.bsky.social · 26/09/2026

#EANO2026 continues in #Rome on another beautiful day ☀️ This morning, don’t miss: ➡️selected abstracts sessions 📄 ➡️pro/contra debate on chemo-RT for IDH-mutant grade 3 gliomas, from Susan Short and Martin van den Bent 🧠 Looking forward to another full day of science and discussion! #radiotherapy

021

Reposted by EANO

Raffaella De Pietro @rdepietro.bsky.social · 26/09/2026

Prof. Susan Short made the Pro case for #radiotherapy + chemotherapy in every patient with grade 3 IDH-mutant #glioma. A great debate around which treatments we can, and should, deliver to this population #EANO2026

021

Reposted by EANO

mquattro.bsky.social @mquattro.bsky.social · 26/09/2026

Extremely nice to see a large Polish delegation at @EANOassociation #EANO2026 - recently formed Polish Society for Neuro-Oncology is represented well at this year’s meeting! Makes me very happy 😃

011

Reposted by EANO

Raffaella De Pietro @rdepietro.bsky.social · 26/09/2026

Poster session time at #EANO2026! Don’t miss the opportunity to have engaging discussions with presenters and colleagues 🗣️ Here few posters that caught my attention 👇🏻 Go and check it out yourselves #RadiationOncology #NeuroOncology

021

EANO @eanoassociation.bsky.social · 26/09/2026

📢 Just presented at #EANO2026 – and now published in Neuro-Oncology! The study “Plasma proteomics for prognostic stratification in newly diagnosed primary central nervous system lymphoma”, presented by first author Tamara Künzle, is now available in Neuro-Oncology. 🔗 doi.org/10.1093/neuo...

010

EANO @eanoassociation.bsky.social · 26/09/2026

📢 Just presented at #EANO2026 – now published in Neuro-Oncology! The study “Potentially Inappropriate Care at the End of Life in Patients with Glioblastoma: A Single-Center Observational Cohort Study”, presented by first author Robin Pieterman, is now available open access. 🔗 doi.org/10.1093/neuo...

032

EANO @eanoassociation.bsky.social · 26/09/2026

Day 2 of the #EANO2026 scientific programme is underway in Rome! Another full day of high-level science, clinical advances & exchange across all disciplines in #NeuroOncology awaits. 📍Don’t miss today’s highlights, presented in comments: Full programme: www.eano.eu/eano2026/pro... #BrainTumor #EANO

110

Reposted by EANO

Raffaella De Pietro @rdepietro.bsky.social · 25/09/2026

At #EANO2026, #EORTC 2227-LEGATO trial is addressing an important question: does adding #reirradiation to lomustine improve outcomes compared with lomustine alone in #glioblastoma? Hopefully this phase III trial will generate the evidence needed to define the role of reRT at first progression.

021

Reposted by EANO

Raffaella De Pietro @rdepietro.bsky.social · 25/09/2026

Poster session time at #EANO2026! 🧠 If you’re around, don’t miss the #Radiotherapy poster section as well. Lots of interesting work on RT, from quality assurance, dose, and treatment #RadiationOncology #NeuroOncology #RTQA #Radiotherapy

021

EANO @eanoassociation.bsky.social · 25/09/2026

Congratulations to Steven Pollard on receiving the #EANO Research Award 2026 at #EANO2026 in #Rome! The award recognises his outstanding contributions to #NeuroOncology research, particularly his work advancing our understanding of glioblastoma biology & cancer stem cells. Congratulations, Steven! 👏

041

EANO @eanoassociation.bsky.social · 25/09/2026

👏 Congratulations to Susan Short on receiving the #EANO Diversity and Inclusion Award 2026 at #EANO2026 in #Rome! This award recognises her long-standing commitment to diversity and inclusion within EANO and the wider #NeuroOncology community. Thank you, Susan, for your outstanding commitment!

010

Reposted by EANO

European Organisation for Research and Treatment of Cancer @eortc.org · 25/09/2026

👏Raffaella presenting at #EANO2026 today. The ARGOS post hoc analysis of EORTC-1709-BTG/CCTG CE.8 (MIRAGE) explored the relationship between radiotherapy quality assurance (RTQA), uninvolved-brain dose, survival, and treatment-related toxicity in patients with glioblastoma.

011

Reposted by EANO

European Organisation for Research and Treatment of Cancer @eortc.org · 25/09/2026

👏 International academic collaboration delivering answers. Just presented at #EANO2026, the ROAM/EORTC-1308 phase III trial found that radiotherapy significantly reduces recurrence risk after complete resection of atypical meningioma. 🔗 www.eortc.org/blog/2026/09... @eanoassociation.bsky.social

042

EANO @eanoassociation.bsky.social · 25/09/2026

Congratulations to Michael Weller on receiving the prestigious #EANO Leadership Award 2026 at #EANO2026 in #Rome! This award recognises his outstanding contributions to #NeuroOncology and his long-standing commitment to EANO. Thank you for helping shape EANO and the field of neuro-oncology!

021

Reposted by EANO

Felix Ehret @felixehretmd.bsky.social · 25/09/2026

We have waited more than a decade for this: ROAM is presented in Rome! See the results of ROAM/EORTC-1308, now also published in @thelancet.com! www.thelancet.com/journals/lan... @eanoassociation.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @galldiks.bsky.social @rdepietro.bsky.social

053

EANO @eanoassociation.bsky.social · 25/09/2026

Highlighting the #EANO2026 Awardees! Congratulations to Isabelle Rydén on receiving the #EANO Nurse & Allied Health Professional Award 2026 at #EANO2026 in #Rome!

010

Reposted by EANO

Raffaella De Pietro @rdepietro.bsky.social · 25/09/2026

ROAM in Rome at #EANO2026 ! Results from the EORTC 1308/ROAM trial: in resected WHO grade 2 #meningioma, adjuvant #radiotherapy improved 5-year DFS compared with observation (79.9% vs 62.3%; HR 0.51). Important evidence for a long-debated question! @eanoassociation.bsky.social @eortc.org

021

EANO @eanoassociation.bsky.social · 25/09/2026

📢 Just presented at #EANO2026 – and now published simultaneously in @thelancet.com! Results from the international multicentre randomised controlled ROAM/EORTC1308 trial, addressing radiotherapy vs. observation following surgical resection of atypical meningioma. 👉 www.thelancet.com/journals/lan...

152

EANO @eanoassociation.bsky.social · 25/09/2026

Welcome to #EANO2026! It’s official – Europe’s largest neuro-oncology congress is underway in Rome! We are delighted to have the global #NeuroOncology community with us and look forward to three inspiring days of scientific exchange, new connections and great conversations. 🇮🇹 #EANO #Rome

021

Reposted by EANO

Felix Ehret @felixehretmd.bsky.social · 24/09/2026

What a start to this year’s #EANO in the eternal city - the education day, the EANO Youngsters Pro/Con session, and the welcome reception were amazing! @eanoassociation.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @galldiks.bsky.social @rdepietro.bsky.social

065

Reposted by EANO

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 24/09/2026

🧠 EANO-ESTRO Joint Session at #EANO2026 Join “Toward Precision and Cognitive-Sparing Radiotherapy in Gliomas” and hear from the ESTRO speakers 📅 27 Sep | 🕘 09:00–10:30 CEST 📍 Sinopoli Hall, Rome 👉 bit.ly/4hJiFy7 #ESTRO #EANO #Radonc

044

Reposted by EANO

Raffaella De Pietro @rdepietro.bsky.social · 24/09/2026

#EANO2026 Educational Day is underway, and later today don’t miss the Pro/Con session on two key radiation oncology questions: proton therapy in IDH-mutant gliomas and local vs systemic treatment for active breast cancer brain metastases 🧠 #RadiationOncology #NeuroOncology

031

Reposted by EANO

Maximilian Mastall @maxmastall.bsky.social · 24/09/2026

#EANO2026 has started with an informative educational day and the main meeting is ongoing now with an exciting session on novel immunotherapeutic approaches being presented. #CART

132

EANO @eanoassociation.bsky.social · 25/09/2026

The #EANO2026 scientific programme kicks off today! Following yesterday’s Educational Day, we are looking forward to a packed programme of scientific sessions, new insights and exchange across the international #NeuroOncology community. Explore today’s programme 👉 www.eano.eu/eano2026/pro...

010

EANO @eanoassociation.bsky.social · 24/09/2026

🧠 A day to learn across disciplines at #EANO2026! Today’s EANO Educational Day took us across the many disciplines that shape modern #NeuroOncology – from #Neurosurgery, #Neuroradiology and #Neuropathology to #RadiationOncology, #Nursing and other #AHPs. Thanks to all involved! #NeuroOncology

001

EANO @eanoassociation.bsky.social · 24/09/2026

The #EANO2026 Educational Day kicks off today in #Rome! A full day dedicated to in-depth learning across #NeuroOncology – from clinical practice to translational science – bringing together experts and trainees in the field. Learn more 👉https://www.eano.eu/eano2026/programme/

030

EANO @eanoassociation.bsky.social · 23/09/2026

Get ready for #EANO2026 in Rome! We look forward to welcoming the global #NeuroOncology community to #Rome – one of the world’s most fascinating cities and the setting for our dedicated Educational Day & three inspiring days of cutting-edge science, exchange & collaboration. #BrainTumor #btsm #EANO

021

EANO @eanoassociation.bsky.social · 22/09/2026

🗓️ Just 2 days to go until #EANO2026! More award-winning science to look forward to: Congrats to Michael D. Jenkinson, selected to receive the Best Oral Presentation Award in Clinical Research! He will present ROAM/EORTC1308 – Radiation vs. observation after surgery 📍Plenary Session | FRI, 25 Sept

142

Reposted by EANO

EANO @eanoassociation.bsky.social · 18/09/2026

📢 Abstract submission is now open! Share your latest research at the CNS Metastasis Meeting 2027, co-organized by a joint effort between @eanoassociation.bsky.social and @eortc.org. 👉 Submit your abstract now: www.eano.eu/eanomeetings... #NeuroOncology #CNS

012

EANO @eanoassociation.bsky.social · 21/09/2026

📱 The countdown is on: Make the most of #EANO2026 with the official congress app! Access the full programme, plan your sessions, connect with fellow attendees, and stay up to date throughout the event. Get started: www.eano.eu/eano2026/myc... #NeuroOncology #BrainTumors #btsm

010

EANO @eanoassociation.bsky.social · 20/09/2026

🎙️ Our special #EANO2026 series of Neuro-Oncology: The Podcast continues! Mihaela Lorger, Chair, & Matthijs van der Meulen, Next Chair of the EANO Educational Committee, join host Iris Verploegh to explore what participants can expect from this year’s Educational Day. 🎧 t1p.de/gayvh #NeuroOncology

034

Reposted by EANO

Giorgio Seano @giorgioseano.bsky.social · 18/09/2026

Very, really honored by this... thank you to the EANO Scientific Committee!! The credit is shared with my co-first authors, Juliette Reveilles and Cathy Pichol-Thievend, and with the whole team. Looking forward to this amazing meeting in Rome! #EANO2026

031

EANO @eanoassociation.bsky.social · 18/09/2026

012

EANO @eanoassociation.bsky.social · 18/09/2026

⏱️ The countdown to #EANO2026 is on – and we are starting with a glimpse of the outstanding science awaiting us in Rome. Happy to announce one of this year’s Congress Awards: Congratulations to Giorgio Seano, selected to receive the Best Oral Presentation Award in Basic Research! #NeuroOncology

030

EANO @eanoassociation.bsky.social · 17/09/2026

💡 #EANO2026 is around the corner, and we are very proud to present this year’s EANO Ambassadors! Follow them on LinkedIn and/or Bluesky for a range of expert insights, and join the conversation using the official hashtag #EANO2026. We look forward to meeting you all in #Rome! #NeuroOncology #btsm

141

EANO @eanoassociation.bsky.social · 16/09/2026

🎉 We are proud to see the EANO Nurses & Allied Health Professionals (NAC) LinkedIn Group reach 500 members! Not a member yet? If you’re a nurse or allied health professional interested in neuro-oncology, we invite you to join the group & connect with colleagues. 👉 www.linkedin.com/groups/12675...

010

EANO @eanoassociation.bsky.social · 26/08/2026

Towards a more consistent assessment of MRI abnormalities after radiotherapy – published in Neuro-Oncology: ESTRO, ESNR and EORTC consensus-based definition for MRI abnormalities after radiotherapy for intracranial central nervous system tumours 👉 doi.org/10.1093/neuo... #EANOessentials

110

EANO @eanoassociation.bsky.social · 26/08/2026

New insights into the tumor microenvironment in brain metastasis – recently published in Cancer Research: MIF-Induced CD74⁺ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders 👉 doi.org/10.1158/0008... #EANOessentials

140

EANO @eanoassociation.bsky.social · 17/08/2026

Insights into professional well-being in neuro-oncology – recently published in Neuro-Oncology: Professional Grief, Burnout and Coping among Neuro-Oncologists: A Cross-Sectional Online Study (PROGRESS) The results will be presented at #EANO2026. 👉 pubmed.ncbi.nlm.nih.gov/42479169/ #EANOessentials

021

EANO @eanoassociation.bsky.social · 11/08/2026

New clinical-trial data on management of low-grade #glioma in Journal of Clinical Oncology: #Temozolomide Vs #Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU) ascopubs.org/doi/10.1200/... #EANOessentials

000

EANO @eanoassociation.bsky.social · 11/08/2026

𝗠𝗲𝗻𝗶𝗻𝗴𝗶𝗼𝗺𝗮 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟲 – just two days left to benefit from the early registration rate! Join us in Rome on 28 September 2026, immediately following #EANO2026, for a dedicated day exploring the latest advances in meningioma research and clinical care. Register by 12 August 2026. #Meningioma #Rome

011

EANO @eanoassociation.bsky.social · 10/08/2026

#EANO is inviting applications to host the EANO Seminar 2028 – an educational event dedicated to advances in CNS tumor pathogenesis and management for junior professionals across Europe. 📅 Apply by October 15, 2026 to office@eano.eu. 👉 www.eano.eu/eanomeetings... #EANO #EANOseminars2028 #CNS

000